Carton Label (Carton)
Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 51817-586
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 51817-586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmascience Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bortezomib Chemical Structure (Chemical Structure)
Graph (Time to progression)
Graph (Overall survival)
Graph (Time to progression)
This is a graph displaying the proportion of patients who received Bortezomib over time (in days) compared to the proportion of patients who received Doxamethasone. The p-value from the log-rank test is less than 0.00017, indicating a statistically significant difference between the two groups. The number of patients remaining at each time point is also given.*
Graph (Overall survival)
This text represents the proportion of patients receiving Bortezomib and Dexamethasone at different time points. There is a statistical significance between the two treatments represented by a p-value obtained through a log-rank test. However, further information is not available to provide more context.*
Progression Free Survival (Figure5)
This appears to be a table representing different subjects and their performance over time. The subjects are labeled as "VeR-CAP" and "RCHOP" and the performance is measured based on the month. The table seems to have columns displaying the months and percentage values. A detailed analysis is difficult without a better understanding of the source material.*
Overall Survival (Figure6)
This is a graph that shows the survival rate of subjects enrolled in a clinical trial for two treatments named VGR-CAP and R-CHOP. The Hazard Ratio value is also provided. It is not possible to determine the type of clinical trial, medical condition or treatment details as the text contains limited information.*
Vial Label (Vial)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
